Management of Node-Positive and Oligometastatic Prostate Cancer

被引:8
|
作者
Broughman, James R. [1 ,2 ]
Chen, Ronald C. [1 ,2 ,3 ]
机构
[1] Univ North Carolina Chapel Hill, Dept Radiat Oncol, CB 7512, Chapel Hill, NC 27599 USA
[2] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC USA
[3] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
关键词
STEREOTACTIC BODY RADIOTHERAPY; METASTATIC COLORECTAL-CANCER; DELAYED ENDOCRINE TREATMENT; TERM-FOLLOW-UP; RADICAL PROSTATECTOMY; ANDROGEN-DEPRIVATION; RADIATION-THERAPY; LOCAL TREATMENT; HEPATIC RESECTION; PRIMARY TUMOR;
D O I
10.1016/j.semradonc.2016.08.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Historically, stage IV prostate cancer was considered incurable. Although node-positive and oligometastatic prostate cancers are both classified as stage IV, these likely represent distinct clinical groups, and some patients may be curable with aggressive multimodality treatments. There is a lack of randomized evidence, but retrospective studies suggest that radical prostatectomy or radiotherapy may improve survival in these patients. This is an area of great current research interest and prospective randomized trials are needed to help define the optimal treatments for these patients. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:79 / 86
页数:8
相关论文
共 50 条
  • [31] Immediate hormonal therapy vs observation in node-positive prostate cancer
    不详
    ONCOLOGY-NEW YORK, 2000, 14 (02): : 168 - 168
  • [32] Safety and Efficacy of Ultra-hypofractionation in Node-positive Prostate Cancer
    Telkhade, T.
    Murthy, V
    Kanala, T. S.
    Mathew, J. M.
    Phurailatpam, R.
    Mokal, S.
    Chourasiya, D.
    Panigrahi, G.
    Krishnatry, R.
    CLINICAL ONCOLOGY, 2021, 33 (03) : 172 - 180
  • [33] Radiotherapy in patients with node-positive prostate cancer after radical prostatectomy
    Jia, Angela Y.
    Spratt, Daniel E.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (01) : 1 - 2
  • [34] Socioeconomic disparities in the receipt of radiation for node-positive prostate cancer.
    Muralidhar, Vinayak
    Mahal, Brandon Arvin Virgil
    Chen, Yu-Wei
    Nezolosky, Michelle Daniel
    Nguyen, Paul L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [35] The role of adjuvant radiotherapy in pathologically lymph node-positive prostate cancer
    Jegadeesh, Naresh
    Liu, Yuan
    Zhang, Chao
    Zhong, Jim
    Cassidy, Richard J.
    Gillespie, Theresa
    Kucuk, Omer
    Rossi, Peter
    Master, Viraj A.
    Alemozaffar, Mehrdad
    Jani, Ashesh B.
    CANCER, 2017, 123 (03) : 512 - 520
  • [36] Impact of Adjuvant Radiotherapy on Survival of Patients With Node-Positive Prostate Cancer
    Abdollah, Firas
    Karnes, R. Jeffrey
    Suardi, Nazareno
    Cozzarini, Cesare
    Gandaglia, Giorgio
    Fossati, Nicola
    Vizziello, Damiano
    Sun, Maxine
    Karakiewicz, Pierre I.
    Menon, Mani
    Montorsi, Francesco
    Briganti, Alberto
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (35) : 3939 - U222
  • [37] Management of Node-Positive Endometrial Cancer With Multimodality Adjuvant Therapy
    Klopp, A. H.
    Jhingran, A.
    Juloori, A.
    Perinjelil, V.
    Broaddus, R.
    Lu, K.
    Eifel, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S455 - S455
  • [38] Node-positive Nonmetastatic Prostate Cancer: Time to Reconsider Prognostic Staging?
    Shinde, Ashwin
    Li, Richard
    Glaser, Scott
    Amini, Arya
    EUROPEAN UROLOGY, 2019, 75 (03) : 355 - 357
  • [39] Is It Time To Change the Treatment Paradigm for Lymph Node-Positive Prostate Cancer?
    Spahn, Martin
    EUROPEAN UROLOGY, 2014, 66 (02) : 200 - 201
  • [40] Management of Lymph Node-positive Penile Cancer: A Systematic Review
    Sachdeva, Ashwin
    McGuinness, Luke
    Zapala, Lukasz
    Greco, Isabella
    Garcia-Perdomof, Herney Andres
    Kailavasan, Mithun
    Antunes-Lopes, Tiago
    Ayresi, Benjamin
    Barretoj, Lenka
    Campi, Riccardo
    Crook, Juanita
    Johnstone, Peter
    Kumar, Vivek
    Manzie, Kenneth
    Marcusp, Jack David
    Necchi, Andrea
    Oliveira, Pedro
    Osborne, John
    Pagliaro, Lance C.
    Protzel, Chris
    Rumble, R. Bryan
    Martinez, Diego F. Sanchez
    Spiess, Philippe E.
    Tagawa, Scott T.
    van der Heijden, Michiel S.
    Parnham, Arie S.
    Pettaway, Curtis A.
    Albersen, Maarten
    Sangar, Vijay K.
    Brouwer, Oscar R.
    Sakalis, Vasileios I.
    EUROPEAN UROLOGY, 2024, 85 (03) : 257 - 273